Premier Biomedical, Inc. (BIEI)
Stock Price: $0.0018 USD
0.0001 (5.88%)
Updated Jun 15, 2021 10:13 AM EDT - Market open
| Market Cap | 1.75M |
| Revenue (ttm) | 14,281 |
| Net Income (ttm) | -374,470 |
| Shares Out | 52.40M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 15 |
| Last Price | $0.0018 |
| Previous Close | $0.0017 |
| Change ($) | 0.0001 |
| Change (%) | 5.88% |
| Day's Open | 0.0018 |
| Day's Range | 0.0017 - 0.0018 |
| Day's Volume | 339,596 |
| 52-Week Range | 0.0007 - 0.0045 |
News
There are no news available yet.
About BIEI
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | Founded 2010 |
| CEO William Hartman | Country United States |
| Stock Exchange OTCMKTS | Ticker Symbol BIEI |
Financial Performance
In 2019, BIEI's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.